Gyon Technologies Capital Management’s Novo Nordisk NVO Stock Holding History

Gyon Technologies Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-38,872	Closed	-$2.17M	–	543
2022 Q2	$2.17M	Buy	+38,872	New	+$2.16M	0.61%	46
2022 Q1	–	Sell	-12,402	Closed	-$695K	–	471
2021 Q4	$695K	Sell	12,402 -718	-5%	-$38.9K	0.13%	221
2021 Q3	$630K	Sell	13,120 -1,580	-11%	-$76.4K	0.17%	178
2021 Q2	$616K	Buy	14,700 +5,400	+58%	+$209K	0.2%	157
2021 Q1	$314K	Buy	+9,300	New	+$331K	0.14%	261
2020 Q4	–	Sell	-15,028	Closed	-$522K	–	414
2020 Q3	$522K	Buy	+15,028	New	+$501K	0.41%	94
2020 Q2	–	Sell	-48,956	Closed	-$1.47M	–	128
2020 Q1	$1.47M	Buy	+48,956	New	+$1.46M	2.83%	5

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Gyon Technologies Capital Management's NVO Position: Q3 2022 in Review

Gyon Technologies Capital Management sold out of Novo Nordisk (NVO) in Q3 2022, closing a stake of 38,872 shares — an estimated $2.17M sold.

Gyon Technologies Capital Management first reported a position in NVO in Q1 2020 and held it in 7 quarters. The position peaked at $2.17M in Q2 2022. 908 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

Gyon Technologies Capital Management reported no remaining Novo Nordisk position as of Q3 2022 after selling out during the quarter.
Gyon Technologies Capital Management sold 38,872 Novo Nordisk shares in Q3 2022, an estimated $2.17M.
Gyon Technologies Capital Management first reported a position in Novo Nordisk in Q1 2020 and held it in 7 quarters.
Gyon Technologies Capital Management's Novo Nordisk position peaked at $2.17M in Q2 2022.
908 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.